| Disaggregation of Revenue |
The following tables disaggregate our revenue from contracts with customers by business unit and geographic region (in millions). Generally, we allocate revenue from contracts with customers to geographic regions based on the location where the sale originated. We have revised prior periods to conform to current year presentation. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | 2026 | | 2025 | | Businesses | U.S. | | Int'l | | Total | | U.S. | | Int'l | | Total | | Endoscopy | $ | 491 | | | $ | 303 | | | $ | 793 | | | $ | 456 | | | $ | 281 | | | $ | 737 | | | Urology | 503 | | | 181 | | | 684 | | | 499 | | | 178 | | | 676 | | | Neuromodulation | 257 | | | 84 | | | 341 | | | 228 | | | 75 | | | 303 | | | MedSurg | 1,251 | | | 567 | | | 1,818 | | | 1,183 | | | 534 | | | 1,716 | | | Interventional Cardiology & Vascular Therapies | 586 | | | 746 | | | 1,333 | | | 499 | | | 679 | | | 1,178 | | | Watchman | 459 | | | 48 | | | 507 | | | 446 | | | 40 | | | 486 | | | Electrophysiology | 606 | | | 310 | | | 916 | | | 587 | | | 252 | | | 840 | | | Cardiac Rhythm Management | 349 | | | 236 | | | 585 | | | 355 | | | 235 | | | 590 | | | Interventional Oncology & Embolization | 175 | | | 108 | | | 283 | | | 155 | | | 96 | | | 251 | | | Cardiovascular | 2,175 | | | 1,449 | | | 3,624 | | | 2,042 | | | 1,303 | | | 3,345 | | | Total Net Sales | $ | 3,426 | | | $ | 2,017 | | | $ | 5,442 | | | $ | 3,224 | | | $ | 1,837 | | | $ | 5,061 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, | | 2026 | | 2025 | | Businesses | U.S. | | Int'l | | Total | | U.S. | | Int'l | | Total | | Endoscopy | $ | 937 | | | $ | 593 | | | $ | 1,529 | | | $ | 876 | | | $ | 534 | | | $ | 1,410 | | | Urology | 967 | | | 363 | | | 1,330 | | | 967 | | | 342 | | | 1,310 | | | Neuromodulation | 494 | | | 166 | | | 659 | | | 432 | | | 142 | | | 574 | | | MedSurg | 2,398 | | | 1,121 | | | 3,519 | | | 2,275 | | | 1,018 | | | 3,293 | | | Interventional Cardiology & Vascular Therapies | 1,139 | | | 1,438 | | | 2,577 | | | 966 | | | 1,337 | | | 2,302 | | | Watchman | 921 | | | 93 | | | 1,014 | | | 836 | | | 75 | | | 911 | | | Electrophysiology | 1,209 | | | 612 | | | 1,821 | | | 1,099 | | | 472 | | | 1,570 | | | Cardiac Rhythm Management | 698 | | | 465 | | | 1,163 | | | 713 | | | 455 | | | 1,168 | | | Interventional Oncology & Embolization | 344 | | | 207 | | | 551 | | | 296 | | | 183 | | | 479 | | | Cardiovascular | 4,311 | | | 2,815 | | | 7,126 | | | 3,909 | | | 2,521 | | | 6,430 | | | Total Net Sales | $ | 6,709 | | | $ | 3,936 | | | $ | 10,646 | | | $ | 6,185 | | | $ | 3,539 | | | $ | 9,724 | |
Refer to Note J – Segment Reporting for information on our reportable segments.
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | Geographic Regions | 2026 | | 2025 | | 2026 | | 2025 | | U.S. | $ | 3,426 | | | $ | 3,224 | | | $ | 6,709 | | | $ | 6,185 | | | Europe, Middle East and Africa | 932 | | | 878 | | | 1,864 | | | 1,725 | | | Asia-Pacific | 878 | | | 790 | | | 1,682 | | | 1,491 | | | Latin America and Canada | 206 | | | 169 | | | 391 | | | 324 | | | Total Net Sales | $ | 5,442 | | | $ | 5,061 | | | $ | 10,646 | | | $ | 9,724 | |
|